NEW YORK, NY (October 8, 2007) --
Dr. Gerald B. Appel, one of the world’s most prominent kidney disease physicians
and NBA star Alonzo Mourning’s personal doctor, has
been named to the Scientific Advisory Board (SAB) of the
NephCure Foundation.
The NephCure Foundation is a non-profit
organization committed to seeking a cure for two debilitating
kidney conditions, Nephrotic Syndrome and Focal Segmental
Glomerulosclerosis (FSGS). FSGS is the disease that interrupted
the career of Mourning, who is now playing again in the NBA
following a kidney transplant.
Appel, a Professor of Clinical
Medicine and Director of Clinical Nephrology at Columbia
University, is one of 11 SAB members who review research
progress and funding priorities of the NephCure Foundation.
Appel
joins Dr. Peter Mundel of The Samuel Bronfman Department
of Medicine at the Mount Sinai School of Medicine as a
new appointee to the SAB.Appel will be honored on November
13 at “Countdown
to a Cure 2007,” the foundation’s third annual
awards presentation at Terrace on the Park in Flushing Meadow
Park, NY. He will be receive the 2007 NephCure Service
Award for his leadership in furthering kidney disease research.
“The
board features an impressive group of experts and I hope
to make an impact,” said Appel. “The
NephCure Foundation has made tremendous progress in just
the past few years and I am privileged to be involved.”
“The
addition of Dr. Appel to the Nephcure SAB broadens the clinical
science expertise available to Nephcure,” offered
Dr. Lawrence B. Holzman, Professor of Internal Medicine at
the University of Michigan. “He is an influential
and widely recognized expert in the care of patients with
glomerular disease, and we look forward to utilizing his
talents and expertise.” Holzman is Chairman of the
SAB.
Appel went to Cornell University
and graduated Phi Beta Kappa in three years before attending
Albert Einstein College of Medicine. He completed three years of residency
training in internal medicine at Columbia Presbyterian Medical
Center and then fellowships in Nephrology at Columbia University
and at Yale New Haven Medical Center. He has served
as president of the New York Society of Nephrology and on
Medical Advisory Boards of the New York-New Jersey branch
of the National Kidney Foundation.
He is a director of the
Glomerular Disease Center at Columbia University and spends
his time pursuing clinical research, patient care and teaching.
About the NephCure Foundation: The
NephCure Foundation, established as a non-profit organization
in 1999, is the only organization solely committed to seeking
a cause and cure for devastating kidney conditions that result
in Nephritic Syndrome or Focal Segmental Glomerulosclerosis
(FSGS). The NephCure Foundation is made up of patients, their
families and friends, researchers, physicians and other healthcare
professionals joining forces to create awareness and generate
funding for research. Further information can be obtained
at www.nephcure.org or
by calling 610-540-0184. |